128 related articles for article (PubMed ID: 22044360)
1. Refractory symptoms successfully treated with leukotriene inhibition in a child with systemic mastocytosis.
Turner PJ; Kemp AS; Rogers M; Mehr S
Pediatr Dermatol; 2012; 29(2):222-3. PubMed ID: 22044360
[TBL] [Abstract][Full Text] [Related]
2. Interactive medical case. A rash hypothesis.
Ross JJ; Saavedra A; Vleugels RA; Liu A; Castells MC
N Engl J Med; 2010 Jun; 362(24):e69. PubMed ID: 20560180
[No Abstract] [Full Text] [Related]
3. Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.
Tolar J; Tope WD; Neglia JP
N Engl J Med; 2004 Feb; 350(7):735-6. PubMed ID: 14960756
[No Abstract] [Full Text] [Related]
4. Long term treatment with montelukast and levocetirizine combination in persistent allergic rhinitis: review of recent evidence.
Adsule SM; Misra D
J Indian Med Assoc; 2010 Jun; 108(6):381-2. PubMed ID: 21121394
[TBL] [Abstract][Full Text] [Related]
5. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
Ciprandi G; Tosca MA; Milanese M; Schenone G; Ricca V
Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
[TBL] [Abstract][Full Text] [Related]
6. The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis.
Bouchelouche K; Nordling J; Hald T; Bouchelouche P
J Urol; 2001 Nov; 166(5):1734-7. PubMed ID: 11586212
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of montelukast monotherapy in moderate persistent asthmatic children.
Igde M; Anlar FY
Iran J Allergy Asthma Immunol; 2009 Sep; 8(3):169-70. PubMed ID: 20124610
[TBL] [Abstract][Full Text] [Related]
8. Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis.
Gülen T; Hägglund H; Dahlén SE; Sander B; Dahlén B; Nilsson G
Lancet; 2014 May; 383(9928):1608. PubMed ID: 24792857
[No Abstract] [Full Text] [Related]
9. Pilot study on recurrent aphthous stomatitis (RAS): a randomized placebo-controlled trial for the comparative therapeutic effects of systemic prednisone and systemic montelukast in subjects unresponsive to topical therapy.
Femiano F; Buonaiuto C; Gombos F; Lanza A; Cirillo N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):402-7. PubMed ID: 19926502
[TBL] [Abstract][Full Text] [Related]
10. Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients.
Patel P; Patel D
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):287-94. PubMed ID: 18814452
[TBL] [Abstract][Full Text] [Related]
11. [Montelukast].
Münzel F; Mühlhäuser U; Eschenhagen T
Dtsch Med Wochenschr; 2002 Nov; 127(44):2337-9. PubMed ID: 12410440
[No Abstract] [Full Text] [Related]
12. Montelukast in childhood asthma.
Mehta PN
Indian Pediatr; 2000 Nov; 37(11):1201-9. PubMed ID: 11086302
[No Abstract] [Full Text] [Related]
13. Oral montelukast and cetirizine for thyroid eye disease.
Lauer SA; Silkiss RZ; McCormick SA
Ophthalmic Plast Reconstr Surg; 2008; 24(4):257-61. PubMed ID: 18645426
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults.
Capella GL; Grigerio E; Altomare G
Eur J Dermatol; 2001; 11(3):209-13. PubMed ID: 11358726
[TBL] [Abstract][Full Text] [Related]
15. Irrational combination of montelukast and bambuterol for management of childhood asthma.
Kabra SK; Lodha R
Indian Pediatr; 2006 Aug; 43(8):743-4. PubMed ID: 16951444
[No Abstract] [Full Text] [Related]
16. Presentation of untreated systemic mastocytosis as recurrent, pulseless-electrical-activity cardiac arrests resistant to cardiac pacemaker.
Butterfield JH; Weiler CR
Int Arch Allergy Immunol; 2014; 163(2):130-4. PubMed ID: 24335343
[TBL] [Abstract][Full Text] [Related]
17. [Importance of leukotriene antagonists in asthma therapy raised].
MMW Fortschr Med; 2008 Mar; 150(13):44-5. PubMed ID: 18522358
[No Abstract] [Full Text] [Related]
18. Malabsorption syndrome and leukotriene inhibitor.
Selva Kumar C; Das RR; Balakrishnan CD; Balagurunathan K; Chaudhuri K
J Trop Pediatr; 2011 Apr; 57(2):135-7. PubMed ID: 20571153
[TBL] [Abstract][Full Text] [Related]
19. Montelukast treatment of urticaria.
McBayne TO; Siddall OM
Ann Pharmacother; 2006 May; 40(5):939-42. PubMed ID: 16670370
[TBL] [Abstract][Full Text] [Related]
20. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.
Chen ST; Lu KH; Sun HL; Chang WT; Lue KH; Chou MC
Pediatr Allergy Immunol; 2006 Feb; 17(1):49-54. PubMed ID: 16426255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
